Observational studyFuture oncology (London, England)2026
A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19.
Liting Guo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.